The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma
Sun-Hee Kim(The University of Texas MD Anderson Cancer Center), Elizabeth A. Grimm(The University of Texas MD Anderson Cancer Center), David G. Menter(The University of Texas MD Anderson Cancer Center), Dai Ogata(Unknown), Weiyi Peng(University of Houston), Sung-Nam Cho(The University of Texas MD Anderson Cancer Center), Jason Roszik(The University of Texas MD Anderson Cancer Center), Denái R. Milton(Cancer Research And Biostatistics), Sühendan Ekmekçioğlu(The University of Texas MD Anderson Cancer Center)
Cited by 55
Related Papers
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
|Clinical Cancer Research|2013|938
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
|Cancer Cell|2018|701
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
|Cancer Cell|2022|338